Thomas E. Griffin serves as Executive at HELIUS MEDICAL TECHNOLOGIES, INC., where they oversee executive responsibilities. Since joining the company, Thomas E. Griffin has executed 5 insider transactions totaling $46.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 21, 2019 involved selling 12,507 shares valued at $0.
Thomas E. Griffin currently holds 12,507 shares of HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas E. Griffin has been a net buyer of HSDT stock. They have purchased $46.0K and sold $0 worth of shares.
Thomas E. Griffin's most recent insider trade was on Nov 21, 2019, when they sold 12,507 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 8, 2019 | AVDR | $26.7K | Option Exercise | 10,000 | $2.67 | Discretionary |
| Feb 19, 2019 | AVDR | $21.0K | Purchase | 1,500 | $14.00 | Discretionary |
| Apr 13, 2018 | HSDT | $25.0K | Purchase | 3,346 | $7.47 | Discretionary |